Blog - Devicare

Devicare and Exeltis signed an agreement to market the Lit-Control in Spain

25 October, 2018

The multinational company Exeltis and the digital therapeutics company Devicare have signed an agreement to market the Lit-Control® family of products in Spain. Lit-Control® is the world's first digital therapeutics solution that allows the most common urological diseases to be prevented and treated effectively from home while also improving patients' adherence to the treatment. This collaboration brings together Exeltis' expertise and excellence in health care with Devicare's experience in product development, intellectual property and clinical research...

Devicare and Premier Medical organise a workshop about advances in the medical treatment of kidney stones in Dublin

11 October, 2018

Devicare and Premier Medical Ltd organised a workshop dedicated to providing an overview of the latest advances in the treatment and clinical handling of lithiasis or kidney stones, on 7 October in Dublin, which was attended by prestigious urologists and Irish health care professionals. The presentation was led by Vera Griffin, Managing Director of Premier Medical Ltd.

Devicare gets the patent for its sensor technology in Europe and USA

6 September, 2018

Devicare has obtained the patent in Europe and the United States for its electrochemical ion sensor, which is integral to the Lit-Control® pH Meter product for frequent urinary conditions, thus making progress in its intellectual and industrial protection strategy and gaining access to key markets in medical and health technologies.

Devicare launches e-commerce site for Lit-Control® in Spain

4 September, 2018

Improving your urinary health is now easier thanks to the new website Lit-control.es. The e-commerce site, designed by Devicare’s digital marketing department, is completely patient-focused: detailed information on Lit-Control® products to monitor urinary pH levels, online purchases and a private area with different functionalities that provide improved know-how and patient empowerment in the management of their health (a record of readings and medical history, order tracking, offers and exclusive discounts...).

Devicare continues its expansion in Latin America

24 July, 2018

Devicare is moving forward in its international expansion by closing licensing and distribution agreements in Argentina, Uruguay and Peru. Various pharmaceutical companies will introduce the products from the Lit-Control® brand to improve the urinary healthcare of the residents of Latin America. The company had previously announced its entry into Mexico and Colombia.

Devicare promotes a pioneering clinical trial to prevent the calcification of double J stent catheters

15 April, 2018

Devicare and nine leading hospitals in urology have started the pioneering international "Double J" study to evaluate the combined use of a medical device and a nutraceutical in controlling urinary pH and inhibiting crystallisation in order to prevent the calcification of double J stent catheters and reduce the number of associated complications.

Devicare, invited to 'The Talents' in Paris

26 March, 2018

The prestigious urologists Manoj Monga of the Cleveland Clinic and Olivier Traxer of the Sorbonne and Pierre and Marie Curie University are organising the first The Talents (The Trans-Atlantic Leaders in Endourological Technologies) symposium, from 5 to 7 April in Paris, in order to build bridges between young European and North American leaders in the field of endourology.

Devicare successfully presents Lit-Control in the European Urology Congress

20 March, 2018

The 33rd European Urology Congress (EAU 2018) closed its doors yesterday in Copenhagen with excellent figures: 15,000 urologists, 160 companies and 2,000 business representatives. Devicare has been present in the exhibition area together with one of its international partners presenting Lit-Control®, the first medical solution which allows recurrent urinary diseases to be effectively addressed with an innovative solution enabling patients to check their own urinary pH with remote monitoring.

Devicare patents a new sensor for the Lit-Control® pH Meter

9 March, 2018

Devicare has obtained the patent in Spain for a new electrochemical ion sensor, which is the most advanced of its type on the market, improving the features of the Lit-Control pH Meter® medical device for self-monitoring chronic urological diseases (lithiasis, infections, overactive bladder, calcification of urinary catheters, etc.). Specifically, the sensor incorporates a reference electrode that prevents it from drying after its use.

Devicare patents a new sensor for the Lit-Control® pH Meter

11 February, 2018

Devicare has obtained the patent in Spain for a new electrochemical ion sensor, which is the most advanced of its type on the market, improving the features of the Lit-Control pH Meter® medical device for self-monitoring chronic urological diseases (lithiasis, infections, overactive bladder, calcification of urinary catheters, etc.). Specifically, the sensor incorporates a reference electrode that prevents it from drying after its use.